+3,681.4%
MRK vs GSK
+1,741.1%
+1,940.3%
-68.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.1% | -2.2% | -2.2% |
| 7D | -2.9% | -1.3% | -1.6% | -2.3% |
| 30D | -1.0% | +2.7% | -3.8% | -2.3% |
| 3M | +7.0% | +2.7% | +4.3% | +5.7% |
| 6M | +31.4% | +3.3% | +28.1% | +29.5% |
| YTD | +40.1% | +6.5% | +33.6% | +35.7% |
| 1Y | +60.0% | +10.7% | +49.4% | +52.4% |
| 3Y | +55.2% | +64.4% | -9.1% | +21.4% |
| 5Y | +100.1% | +46.7% | +53.4% | +61.8% |
| 10Y | +228.0% | +109.4% | +118.7% | +123.3% |
| All | +3,681.4% | +1,741.1% | +1,940.3% | +874.3% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling